ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 72 filers reported holding ANI PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541 | +31.6% | 9,321 | +22.0% | 0.00% | – |
| Q2 2023 | $411 | +45.2% | 7,639 | +7.0% | 0.00% | – |
| Q1 2023 | $283 | +7.2% | 7,141 | +9.1% | 0.00% | – |
| Q4 2022 | $264 | -99.8% | 6,546 | +50.4% | 0.00% | – |
| Q3 2022 | $140,000 | -35.8% | 4,353 | -40.8% | 0.00% | – |
| Q2 2022 | $218,000 | -34.1% | 7,352 | -37.8% | 0.00% | – |
| Q1 2022 | $331,000 | -77.5% | 11,812 | -63.0% | 0.00% | – |
| Q4 2021 | $1,472,000 | +477.3% | 31,932 | +310.6% | 0.00% | – |
| Q3 2021 | $255,000 | +37.8% | 7,776 | +48.1% | 0.00% | – |
| Q2 2021 | $185,000 | -69.2% | 5,251 | -68.4% | 0.00% | – |
| Q1 2021 | $601,000 | +34.5% | 16,616 | +8.0% | 0.00% | – |
| Q4 2020 | $447,000 | -3.2% | 15,386 | -6.1% | 0.00% | – |
| Q3 2020 | $462,000 | +6.7% | 16,381 | +22.3% | 0.00% | – |
| Q2 2020 | $433,000 | -14.9% | 13,393 | +7.3% | 0.00% | – |
| Q1 2020 | $509,000 | -40.3% | 12,477 | -9.7% | 0.00% | – |
| Q4 2019 | $852,000 | +27.4% | 13,813 | +50.4% | 0.00% | – |
| Q3 2019 | $669,000 | -34.6% | 9,187 | -26.3% | 0.00% | -100.0% |
| Q2 2019 | $1,023,000 | -39.9% | 12,462 | -48.3% | 0.00% | 0.0% |
| Q1 2019 | $1,701,000 | +30.8% | 24,115 | -16.5% | 0.00% | 0.0% |
| Q4 2018 | $1,300,000 | +7.2% | 28,883 | +34.7% | 0.00% | 0.0% |
| Q3 2018 | $1,213,000 | +72.1% | 21,449 | +103.0% | 0.00% | 0.0% |
| Q2 2018 | $705,000 | -32.9% | 10,568 | -41.5% | 0.00% | 0.0% |
| Q1 2018 | $1,051,000 | +44.8% | 18,060 | +60.2% | 0.00% | 0.0% |
| Q4 2017 | $726,000 | +98.4% | 11,275 | +62.0% | 0.00% | – |
| Q3 2017 | $366,000 | +33.1% | 6,960 | +18.3% | 0.00% | – |
| Q2 2017 | $275,000 | -36.0% | 5,882 | -32.4% | 0.00% | – |
| Q1 2017 | $430,000 | -31.6% | 8,697 | -16.1% | 0.00% | -100.0% |
| Q4 2016 | $629,000 | +184.6% | 10,367 | +210.8% | 0.00% | – |
| Q3 2016 | $221,000 | -81.4% | 3,336 | -84.3% | 0.00% | -100.0% |
| Q2 2016 | $1,187,000 | +214.0% | 21,267 | +86.3% | 0.00% | +100.0% |
| Q1 2016 | $378,000 | -67.8% | 11,415 | -56.2% | 0.00% | 0.0% |
| Q4 2015 | $1,173,000 | +83.6% | 26,069 | +59.3% | 0.00% | 0.0% |
| Q3 2015 | $639,000 | -21.4% | 16,362 | +24.6% | 0.00% | 0.0% |
| Q2 2015 | $813,000 | -88.7% | 13,127 | -88.7% | 0.00% | -87.5% |
| Q1 2015 | $7,220,000 | +13784.6% | 116,438 | +12353.3% | 0.01% | – |
| Q4 2014 | $52,000 | -54.8% | 935 | -77.3% | 0.00% | – |
| Q3 2014 | $115,000 | +538.9% | 4,116 | +679.5% | 0.00% | – |
| Q2 2014 | $18,000 | -58.1% | 528 | -61.7% | 0.00% | – |
| Q1 2014 | $43,000 | +7.5% | 1,377 | -29.6% | 0.00% | – |
| Q4 2013 | $40,000 | +122.2% | 1,957 | -0.8% | 0.00% | – |
| Q3 2013 | $18,000 | – | 1,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |